Skip to main content
OpenTrials
Completed

NCT Number: NCT05417763

Sensor-equipped Ultrathin Pressure Microcatheter Versus Pressure Wire for Physiological Measurements

TruePhysio pressure microcatheter is a novel device for evaluating the functional significance of coronary stenosis, and its safety and efficacy on the measurement of hyperemic index have been validated in the previous SUPREME study (NCT03541577). This study will further evaluate the safety and efficacy of the physiological indices measured by the TruePhysio pressure microcatheter, including resting and hyperemic indices, with respect to the physiological indices measured by the Pressure Wire.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Peking University Third Hospital, Beijing, Beijing Municipality, China

Loading trial locations.

About this study

This study will evaluate the safety and efficacy of the constant-resistance ratio (cRR) measured by the TruePhysio pressure microcatheter, in both binary and hybrid strategy, with respect to its own fractional flow reserve (FFR) and the FFR or resting full-cycle ratio (RFR) by the Pressure Wire. And the safety and efficacy of the FFR measured by the TruePhysio pressure microcatheter in patients with a border range of diameter stenosis also be validated with respect to the FFR by the Pressure Wire.

The diagnostic accuracy of cRR by the TruePhysio pressure microcatheter system is evaluated, using FFR measured by both systems as reference;

Mean bias between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire is evaluated, using FFR measured by Pressure Wire as the reference;

The diagnostic accuracy of the hybrid cRR-FFR scheme by the TruePhysio pressure microcatheter is evaluated, using its own FFR as reference;

The diagnostic accuracy of the hybrid RFR-FFR scheme by the Pressure Wire system is evaluated, using its own FFR as reference.

The hybrid scheme for cRR-FFR (pressure microcatheter system), or RFR-FFR (pressure wire system), is defined as following:

  • the gray zone is defined as where the sensitivity and specificity are equal, shown as [A, B].
  • if cRR or RFR of the target vessel is <A, it is diagnosed as functionally positive in myocardial ischemia;
  • if cRR or RFR of the target vessel is >B, it is diagnosed as functionally negative in myocardial ischemia;
  • if cRR or RFR of the target vessel is between A and B (including A and B), the diagnostic criterion is superseded by that of FFR, which is:
  • if FFR of the target vessel is > 0.80, it is diagnosed as functionally negative in myocardial ischemia;
  • if FFR of the target vessel is ≤ 0.80, it is diagnosed as functionally positive in myocardial ischemia.

A total of 487 patients are anticipated to be recruited from 11 centers in China.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years old;
  • Having at least one 30-90% coronary artery stenosis by visual estimation under angiogram;
  • Clinically indicated to physiological assessment.

Exclusion criteria

  • Unable to comprehend, or unwilling to sign the informed consent form;
  • Contraindicated to the procedures of invasive coronary angiography or percutaneous coronary intervention;
  • Clinically diagnosed with severe coronary artery vasospasm;
  • Other operator-discerned facts that will make enrollment or the procedure impossible to complete.

Treatment and study plan

Randomized physiological measurements by the two systems

Device

To measure physiological indices (FFR, cRR and RFR), either pressure microcatheter or pressure wire enters one patient's body. Whether it is the pressure microcatheter or pressure wire firstly to enter is randomized. After completion of one system's physiological assessment, the other system will follow for its physiological assessment.

Primary outcomes

  1. The accuracy of cRR measured by TruePhysio pressure microcatheter in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by TruePhysio pressure microcatheter as the reference. The optimal binary cutoff for cRR is determined by using Youden's index.

Secondary outcomes

  1. The area under the Receiver Operating Characteristic (ROC) curve (AUC) of cRR measured by the TruePhysio pressure microcatheter in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by TruePhysio pressure microcatheter as the reference

  2. The sensitivity, specificity, positive and negative predictive values of cRR measured by TruePhysio pressure microcatheter in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by TruePhysio pressure microcatheter as the reference. The optimal binary cutoff for cRR is determined by using Youden's index.

  3. The AUC of cRR measured by the TruePhysio pressure microcatheter in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by Pressure Wire as the reference

  4. The overall accuracy, sensitivity, specificity, positive and negative predictive values of cRR in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by Pressure Wire as the reference. The optimal binary cutoff for cRR is determined by using Youden's index.

  5. The AUC of RFR measured by the Pressure Wire in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by Pressure Wire as the reference

  6. The overall accuracy, sensitivity, specificity, positive predictive value and negative predictive value of RFR in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by Pressure Wire as the reference. The binary cutoff for RFR is determined by previous study as 0.89.

  7. The overall accuracy, sensitivity, specificity, positive and negative predictive values of the hybrid cRR-FFR scheme, concluded by TruePhysio pressure microcatheter, in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by the TruePhysio pressure microcatheter as the reference. The gray zone is defined as where the false positive and negative ratios are equal.

  8. The proportion of the subcohort, whose cRR value is in the gray zone of the hybrid cRR-FFR scheme, to the entire cohort

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by the TruePhysio pressure microcatheter as the reference. Each enrolled patient only has one vessel to be physiologically assessed.

  9. When the cRR value is out of the gray zone of the hybrid cRR-FFR scheme, the cRR-FFR hybrid scheme's accuracy in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by the TruePhysio pressure microcatheter as the reference

  10. The overall accuracy, sensitivity, specificity, positive and negative predictive values of the hybrid RFR-FFR scheme, concluded by Pressure Wire, in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by the Pressure Wire as the reference. The gray zone is determined by previous study as [0.86, 0.93].

  11. The proportion of the subcohort, whose RFR value is in the gray zone of the hybrid RFR-FFR scheme, to the entire cohort

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by the Pressure Wire as the reference. Each enrolled patient only has one vessel to be physiologically assessed.

  12. When the RFR value is out of the gray zone of the hybrid RFR-FFR scheme, the RFR-FFR hybrid scheme's accuracy in diagnosing myocardial ischemia

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by the Pressure Wire as the reference

  13. Results of Pearson correlation between the cRR and FFR measured by TruePhysio pressure microcatheter

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Paired values are analyzed by Pearson correlation

  14. Results of Passing-Bablok regression analysis between the cRR and FFR measured by TruePhysio pressure microcatheter

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Paired values are analyzed by Passing-Bablok regression

  15. Results of Pearson correlation between the RFR and FFR measured by Pressure Wire

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Paired values are analyzed by Pearson correlation

  16. Results of Passing-Bablok regression analysis between RFR and FFR measured by Pressure Wire

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Paired values are analyzed by Passing-Bablok regression

  17. Results of Passing-Bablok regression analysis between cRR measured by the TruePhysio pressure microcatheter, and RFR measured by the Pressure Wire

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Paired cRR-RFR values by the two systems are analyzed in Passing-Bablok regression

  18. Results of Bland-Altman analysis between cRR measured by the TruePhysio pressure microcatheter, and RFR measured by the Pressure Wire

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Paired cRR-RFR values by the two systems are analyzed in Bland-Altman analysis

  19. Results of Pearson's correlation between cRR measured by the TruePhysio pressure microcatheter, and RFR measured by the Pressure Wire

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Paired cRR-RFR values by the two systems are analyzed in Pearson correlation

  20. Results of Pearson correlation between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Paired FFR values by the two systems are analyzed by Pearson correlation

  21. Results of Passing-Bablok regression analysis between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Paired FFR values by the two systems are analyzed by Passing-Bablok regression

  22. Mean bias between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire as assessed by Bland-Altman analysis

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by Pressure Wire as the reference

  23. Results of Bland-Altman analysis between the FFR values measured by TruePhysio pressure microcatheter and Pressure Wire among the patients with atrial fibrillation or in severe stenosis or with small vessels

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Using FFR measured by Pressure Wire as the reference. The severe stenosis is defined as the diameter stenosis higher than 70%, while the small vessel is defined as the reference vessel diameter smaller than 2.5 mm.

  24. Rate of significant drift

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Drift is defined as the difference between FFR value and 1 when pressure sensor is pulled back to coronary artery ostium for verification.

    Significant drift occurs when the device has a drift with absolute value > 0.03; alternatively, drift is regarded as significant when the Pd/Pa at the ostium for verification is either <0.97 or >1.03.

    Significant drift is recorded per appearance, regardless whether the measurement is eventually successful or not. Its rate is calculated as:

    Times of significant drift occurred in total / Times of measuring attempted in total

  25. Rate of device success

    Time frame: Immediate upon completion of the procedure for the last enrolled patient

    Device success is defined when a device successfully crossed the lesion and completed acquisition of valid physiological values.

    For any vessel, if valid cRR and FFR values by the TruePhysio pressure microcatheter are acquired, the measurement of TruePhysio pressure microcatheter is successful in the specific vessel, disregarding how many times it was attempted;

    For any vessel, if valid RFR and FFR values by the Pressure Wire are acquired, the measurement of Pressure Wire is successful in the specific vessel, disregarding how many times it was attempted.

    Rate of device success is calculated as:

    Vessels with device success / Total vessels

Sponsors and collaborators

Lead sponsor

Insight Lifetech Co., Ltd.

Industry

Collaborators

  • First Affiliated Hospital of Chongqing Medical University
  • First Affiliated Hospital of Harbin Medical University
  • First Affiliated Hospital of Wenzhou Medical University
  • First Affiliated Hospital of Xinjiang Medical University
  • Guangdong Provincial People's Hospital
  • Peking University Third Hospital
  • Shandong Provincial Hospital
  • Shanghai Zhongshan Hospital
  • Sir Run Run Shaw Hospital
  • Xiamen Cardiovascular Hospital, Xiamen University
  • Zunyi Medical College

Registry information

Official study title

Pressure Microcatheter for Physiological Measurements - A Prospective, Multicenter, Randomized Study

Acronym: SUPREME II

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jun 14, 2022
Registry last updated
Dec 20, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.